Diabetes-Related Effectiveness and Cost of Liraglutide or Insulin in German Patients with Type 2 Diabetes: A 5-Year Retrospective Claims Analysis

被引：0
作者：
Thomas Wilke
Sabrina Mueller
Andreas Fuchs
Margit S. Kaltoft
Stefan Kipper
Malgorzata Cel
机构：
[1] Institut für Pharmakoökonomie und Arzneimittellogistik (IPAM) an der Hochschule Wismar,Global Development
[2] Ingress-Health,undefined
[3] AOK PLUS,undefined
[4] Novo Nordisk A/S,undefined
[5] Novo Nordisk Pharma GmbH,undefined
[6] Novo Nordisk Region Europe,undefined
来源：
Diabetes Therapy | 2020年 / 11卷
关键词：
Claims data; Cost; Effectiveness; Germany; Insulin; Liraglutide; Propensity score; Real-world; Type 2 diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2357 / 2370
页数：13
相关论文
共 50 条
  • [31] Clinical Effectiveness of Liraglutide Across Body Mass Index in Patients with Type 2 Diabetes in the United States: A Retrospective Cohort Study
    Abhishek S. Chitnis
    Michael L. Ganz
    Nicole Benjamin
    Jakob Langer
    Mette Hammer
    Advances in Therapy, 2014, 31 : 986 - 999
  • [32] The Effectiveness of Diabetes Conversation Map™ among Insulin Refusal Type 2 Diabetes Mellitus Patients
    Tahir, N. S. Mohd
    Zakaria, R.
    Zulkifli, M.
    Draman, N.
    IIUM MEDICAL JOURNAL MALAYSIA, 2023, 22 (03): : 98 - 104
  • [33] Clinical Effectiveness of Liraglutide vs Sitagliptin on Glycemic Control and Body Weight in Patients with Type 2 Diabetes: A Retrospective Assessment in Sweden
    Marcus Lind
    Per-Olov Matsson
    Ragnar Linder
    Irene Svenningsson
    Leif Jørgensen
    Uffe J. Ploug
    Helge Gydesen
    Mozhgan Dorkhan
    Sara Larsen
    Gunnar Johansson
    Diabetes Therapy, 2016, 7 : 321 - 333
  • [34] Pharmacoeconomic analysis (CER) of Dulaglutide and Liraglutide in the treatment of patients with type 2 diabetes
    Su, Yu
    Zhang, Shuo
    Wu, Zezhen
    Liu, Weiting
    Chen, Jingxian
    Deng, Feiying
    Chen, Fengwu
    Zhu, Dan
    Hou, Kaijian
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [35] Clinical Effectiveness of Liraglutide Across Body Mass Index in Patients with Type 2 Diabetes in the United States: A Retrospective Cohort Study
    Chitnis, Abhishek S.
    Ganz, Michael L.
    Benjamin, Nicole
    Langer, Jakob
    Hammer, Mette
    ADVANCES IN THERAPY, 2014, 31 (09) : 986 - 999
  • [36] A Simulation of the Comparative Long-term Effectiveness of Liraglutide and Glimepiride Monotherapies in Patients with Type 2 Diabetes Mellitus
    Sullivan, Sean D.
    Alfonso-Cristancho, Rafael
    Conner, Chris
    Hammer, Mette
    Blonde, Lawrence
    PHARMACOTHERAPY, 2009, 29 (11): : 1280 - 1288
  • [37] Effectiveness and tolerability of liraglutide in patients with type 2 diabetes mellitus and obesity after bariatric surgery
    Gorgojo-Martinez, Juan J.
    Feo-Ortega, Gara
    Serrano-Moreno, Clara
    SURGERY FOR OBESITY AND RELATED DISEASES, 2016, 12 (10) : 1856 - 1865
  • [38] Social Determinants of Health and Diabetes-Related Distress in Patients With Insulin-Dependent Type 2 Diabetes: Cross-sectional, Mixed Methods Approach
    Levy, Natalie K.
    Park, Agnes
    Solis, Daniela
    Hu, Lu
    Langford, Aisha T.
    Wang, Binhuan
    Rogers, Erin S.
    JMIR FORMATIVE RESEARCH, 2022, 6 (10)
  • [39] Insulin adherence and persistence among Chinese patients with type 2 diabetes: a retrospective database analysis
    He, Xiaoning
    Chen, Liming
    Wang, Ke
    Wu, Haiya
    Wu, Jing
    PATIENT PREFERENCE AND ADHERENCE, 2017, 11 : 237 - 245
  • [40] Persistence with Insulin Therapy in Patients with Type 2 Diabetes in France: An Insurance Claims Study
    Roussel, Ronan
    Charbonnel, Bernard
    Behar, Mourad
    Gourmelen, Julie
    Emery, Corinne
    Detournay, Bruno
    DIABETES THERAPY, 2016, 7 (03) : 537 - 549
12345